CLYM – climb bio, inc. (US:NASDAQ)
Stock Stats
News
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Climb Bio (NASDAQ:CLYM) was downgraded by analysts at Wall Street Zen
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Form SCHEDULE 13D/A Climb Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 4 Climb Bio, Inc. For: Dec 11 Filed by: RA Capital Nexus Fund, L.P.
Form 8-K Climb Bio, Inc. For: Dec 11
Form 10-Q Climb Bio, Inc. For: Sep 30
Form 8-K Climb Bio, Inc. For: Nov 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.